Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
mBio is Scopus-indexed (Q1, CiteScore 8.4), WoS SCIE, DOAJ. It is covered by India's One Nation One Subscription scheme for reading access. Published by American Society for Microbiology.
Checked against the index lists dated .
ISSN 2150-7511Verify ISSN ↗2161-2129Verify ISSN ↗
Publisher: American Society for Microbiology
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Virology | 13 / 86 | 85th | Q1 |
| Microbiology | 40 / 194 | 79th | Q1 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2010–present, best quartile Q1, CiteScore 8.4.
mBio is Q1 in Virology (rank 13 of 86) and Q1 in Microbiology (rank 40 of 194), by CiteScore 2025.
mBio is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 8.4, which places it in quartile Q1 at the 85th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 2.002, quartile Q1, with an H-index of 193.
The publisher lists an article processing charge of about US$3,900 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
mBio is published by American Society for Microbiology. Its print ISSN is 2150-7511 and its online ISSN is 2161-2129.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
mBio has an h-index of 234 and a 2-year mean of 6.03 citations per paper (OpenAlex). Its Scopus CiteScore is 8.4, quartile Q1. On 2-year citations it ranks #6 of 85 Scopus journals in Virology.
mBio published 826 papers in 2025; its busiest recent year was 2021 with 867. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2026), authors are most often from United States (49.4%), China (13.7%) and Australia (3.3%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 11 retracted papers are recorded (1.2 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.